Skip to content

Tempus AI, Inc. TEM Non-cash interest expense

Non-cash interest expense at other companies

Summit Therapeutics logo
Summit TherapeuticsSMMT
$0
DigitalOcean logo
DigitalOceanDOCN
$1.53M-23.8%
Natera, Inc. logo
Natera, Inc.NTRA
-$18K-5.9%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$4.7M-72.5%
EnerSys logo
EnerSysENS
$488K+1.9%
Globalstar logo
GlobalstarGSAT
$23.01M+190%

Other financials

Income statement

See full
Revenue$348.1M+36.1%
Operating income-$84.7M-23.3%
Net income-$125.9M-85.1%
EPS (diluted)-$0.71-77.5%

Balance sheet

See full
Cash & equivalents$525.9M+243%
Total debt$85.4M+49.8%
Total equity$416.4M+27.7%
Total assets$2.1B+38.4%

Cash flow

See full
Operating cash flow-$73.3M+30.6%
CapEx$8.2M+295%
Free cash flow-$81.5M+24.3%

Valuation

See full
Market cap$9.13B-2.7%
Enterprise value$8.69B-6.9%
P/S6.7×-5.0×

Profitability

See full
Operating margin-19.7%-8.6pp
Net margin-22.2%-9.5pp
FCF margin-54.5%

Returns & leverage

See full
Return on equity-81.6%
Debt / equity0.2×0.0×
Current ratio3.3×+1.6×

Where this comes from

Reported directly by Tempus AI, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccretionExpense.

The official record: Tempus AI, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tempus AI, Inc.'s non-cash interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tempus AI, Inc.'s non-cash interest expense?
Tempus AI, Inc. (TEM) reported non-cash interest expense of $57K in Q1 2026.
How has Tempus AI, Inc.'s non-cash interest expense changed year-over-year?
Tempus AI, Inc.'s non-cash interest expense decreased by 77.0% year-over-year, from $248K to $57K.
What does non-cash interest expense mean?
Non-cash interest expense arising from the adjustment of debt carrying values.
How do you interpret non-cash interest expense?
An increase reflects higher non-cash interest charges, often due to debt issuance or specific accounting treatments for debt instruments.
How does non-cash interest expense compare across companies?
Commonly found in companies with significant long-term debt or convertible instruments.